Cost-Effectiveness of Screening and Treating Chronic Hepatitis C Virus Infection in Zimbabwe

Dados Bibliográficos

ID15480591
AutoresBlessing Dzingirai (0000-0001-8208-7821, University Medical Center Groningen, autor correspondente), Leolin Katsidzira (0000-0003-4815-5207, University of Zimbabwe), Maarten J Postma (0000-0002-6306-3653, University Medical Center Groningen), Marinus van Hulst (0000-0003-3216-7246, University Medical Center Groningen), Nyashadzaishe Mafirakureva (0000-0001-9775-6581, University of Sheffield)
Ano2025
Volume22
Fascículo4
Páginas509-509
Data de publicação2025-03-27
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoInternational Journal of Environmental Research and Public Health (JOURNAL)
Identificadores do periódicoISSN: 1661-7827 • E-ISSN: 1660-4601
EditoraMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph22040509
PMID40283735
OpenAlexW4408922694
IdiomaEN
Referências citadas53

Screening for HCV among high-risk populations followed by treatment using sofosbuvir/velpatasvir is cost effective under the assumptions made in this study

Cost effectiveness · Cost-effectiveness analysis · Environmental health · Hepatitis C virus · Incremental cost-effectiveness ratio · Per capita · Population · Quality-adjusted life year · Risk analysis (engineering · Sofosbuvir · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV/AIDS Research and Interventions · Medicine · Immunology